Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy

Author(s):  Rhoads Rick

Issue:  Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Page(s):  129-134

Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 1
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 2
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 3
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 4
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 5
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Page 6

Download in electronic PDF format for $75

Abstract:  Changes in California regulations regarding beyond-use dates of sterile preparations have prompted many compounders to consider stability studies for their formulas. Traditionally, 503A compounders have relied on published data and professional experience to determine stability. However, due to these new regulations, stability studies are now required for California resident and nonresident licensees to extend the beyond-use date of sterile preparations. Conducting studies for the first time can be costly and difficult for compounding pharmacists. This article shares several lessons learned from the author’s experience performing stability studies on Trimix injection, a sterile preparation for erectile dysfunction. Avoiding easily made errors can save the compounder unnecessary time and expense.

Related Keywords: Rick Rhoads, PharmD, QP503A, compounded sterile preparations, sterile compounding, beyond-use dates, stability studies, Trimix injection, erectile dysfunction, California Code of Regulations, time-point testing, bracketing, concentration, starting material potency, pharmacy staff, training

Related Categories: LEGAL, STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS, QUALITY CONTROL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
Mar/Apr 2018
Pg. 129-134

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh
, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021
Pg. 73-81

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Trissel Lawrence A
, Zhang Yanping
May/Jun 2004
Pg. 231-235

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
Nov/Dec 2008
Pg. 524-528

Basics of Compounding: Clinical Studies
Allen Loyd V Jr
Nov/Dec 2002
Pg. 443-447

Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C
, Allen Loyd V Jr
May/Jun 2010
Pg. 232-238

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg
, Yoch Doug
Jan/Feb 2021
Pg. 18-23

Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
Jul/Aug 2018
Pg. 303-312

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William
, Roth Abby
May/Jun 2017
Pg. 193-203

Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon
, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2008
Pg. 344-353

Assignment of a Beyond-Use Date for Compounded Preparations
Allen Loyd V Jr
Nov/Dec 2000
Pg. 474-475

Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
Mar/Apr 2019
Pg. 123-130

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal
, Levesque Dan, Frye John, Rashid Mamoon
Jul/Aug 2020
Pg. 322-326

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Rahe Hank
Mar/Apr 2004
Pg. 89-94

Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
Jul/Aug 2013
Pg. 307-311

Return to Top